Evidence map›Paper›PMID 38347172›Full record

ArticlePediatric research2024

Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19.

Kerri Bertrand, Yadira Sepulveda, Benjamin J Spiegel, Brookie M Best, Raymond Suhandynata, Steven Rossi, Christina D Chambers, Jeremiah D Momper

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kerri BertrandDepartment of Pediatrics, University of California, San Diego, La Jolla, CA, 92093, USA. kdutcher@health.ucsd.edu.
Yadira SepulvedaSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093, USA.
Benjamin J SpiegelSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093, USA.
Brookie M BestDepartment of Pediatrics, University of California, San Diego, La Jolla, CA, 92093, USA.
Raymond SuhandynataSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093, USA.
Steven RossiSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093, USA.
Christina D ChambersDepartment of Pediatrics, University of California, San Diego, La Jolla, CA, 92093, USA.
Jeremiah D MomperSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093, USA.
University of California, San Diego · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
NCATS NIH HHS UL1 TR001442
6 · The paper itself

Abstract

impactFindings from this study provide further reassuring evidence that infant exposure through human milk received from lactating individuals who require treatment with remdesivir is negligible.

Indexed as

Adenosine MonophosphateAlanineAntiviral AgentsCOVID-19 Drug TreatmentLactationMilk, HumanSARS-CoV-2AdenosineAdultCOVID-19FemaleHumansInfantInfant, NewbornAdenosineAdenosine MonophosphateAlanineAntiviral AgentsGS-441524remdesivir

Identifiers

PMID38347172
PMCPMC11343694
OpenAlexW4391746175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.